1-4 of 4
Authors: Corey Laforest-Roys
Journal Article
CTIM-28. NEOADJUVANT ANTI-PD1 IMMUNOTHERAPY FOR SURGICALLY ACCESSIBLE RECURRENT GLIOBLASTOMA: CLINICAL AND MOLECULAR OUTCOMES OF A STAGE 2 SINGLE-ARM EXPANSION COHORT Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii92, https://doi.org/10.1093/neuonc/noae165.0361
Published: 11 November 2024
Journal Article
CTIM-25. NEOADJUVANT ANTI-PD1 IMMUNOTHERAPY FOR SURGICALLY ACCESSIBLE RECURRENT GLIOBLASTOMA: CLINICAL AND MOLECULAR OUTCOMES OF A STAGE 2 SINGLE-ARM EXPANSION COHORT Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii65–vii66, https://doi.org/10.1093/neuonc/noac209.257
Published: 14 November 2022
Journal Article
CTIM-18. PHASE 2 STUDY OF PD-1 BLOCKADE WITH PEMBROLIZUMAB PLUS RE-IRRADIATION FOR RECURRENT GLIOBLASTOMA (RGBM) (NCT03661723) Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii63–vii64, https://doi.org/10.1093/neuonc/noac209.250
Published: 14 November 2022
Journal Article
CTIM-12. RANDOMIZED PHASE 2 STUDY OF NIVOLUMAB (NIVO) PLUS EITHER STANDARD OR REDUCED DOSE BEVACIZUMAB (BEV) IN RECURRENT GLIOBLASTOMA (rGBM) Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii35, https://doi.org/10.1093/neuonc/noaa215.146
Published: 09 November 2020
